USC Diabetes Symposium 2025 - Enduring

1. Identify patients who are candidates for cardio- and renal-protective medications
2. Summarize the benefits of once-weekly insulin therapy
3. Treat obesity in the context of diabetes
4. Integrate strategies for reduction of polypharmacy

The Keck School of Medicine of the University of Southern California designates this Enduring Material activity for a maximum of 575.00 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Cancellation Policy

Cancellations must be received by the USC Office of CME by email only by ____ 12:00 pm PDT for a refund. A $50 cancellation fee will be applied after ____. In the event of course cancellation by conference organizers, all registration fees will be fully refunded. USC will not refund any travel costs incurred.


Accessibility Statement
 
Keck School of Medicine Healthcare System is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008. If you have needs that require special accommodations, including dietary concerns, please contact the USC Office of CME at [email protected].

The Keck School of Medicine Healthcare System School of Medicine adheres to ACCME Criteria, Standards and Policies regarding industry support of continuing medical education. Disclosure of faculty and their commercial relationships will be made prior to the activity.

Mitigation of Relevant Financial Relationships

Keck School of Medicine Continuing Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.